Evidence map›Paper›PMID 26484664›Full record

ArticlePLoS genetics2015

Transcriptional Derepression Uncovers Cryptic Higher-Order Genetic Interactions.

Matthew B Taylor, Ian M Ehrenreich

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Decanalizing thinking on genetic canalization.Seminars in cell & developmental biology · 2019
    Review
  8. Article
  9. Article
  10. Prevalence and patterns of higher-order drug interactions inNPJ systems biology and applications · 2018
    Article
  11. Mapping a diversity of genetic interactions in yeast.Current opinion in systems biology · 2017
    Article
  12. Genetic suppression: Extending our knowledge from lab experiments to natural populations.BioEssays : news and reviews in molecular, cellular and developmental biology · 2017
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Matthew B TaylorMolecular and Computational Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles, California, United States of America.
Ian M EhrenreichMolecular and Computational Biology Section, Department of Biological Sciences, University of Southern California, Los Angeles, California, United States of America.
University of Southern California · US

Funding

Comprehensive dissection of higher-order genetic interactionsR01GM110255 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EHRENREICH, IAN MICHAEL · 2014 to 2018
$1.4M
Genetic basis and pathogenicity of invasive growth in yeastR21AI108939 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EHRENREICH, IAN MICHAEL · 2014 to 2015
$439k
NIAID NIH HHS R21 AI108939NIAID NIH HHS R21AI108939NIGMS NIH HHS R01 GM110255NIGMS NIH HHS R01GM110255
6 · The paper itself

Abstract

Disruption of certain genes can reveal cryptic genetic variants that do not typically show phenotypic effects. Because this phenomenon, which is referred to as 'phenotypic capacitance', is a potential source of trait variation and disease risk, it is important to understand how it arises at the genetic and molecular levels. Here, we use a cryptic colony morphology trait that segregates in a yeast cross to explore the mechanisms underlying phenotypic capacitance. We find that the colony trait is expressed when a mutation in IRA2, a negative regulator of the Ras pathway, co-occurs with specific combinations of cryptic variants in six genes. Four of these genes encode transcription factors that act downstream of the Ras pathway, indicating that the phenotype involves genetically complex changes in the transcriptional regulation of Ras targets. We provide evidence that the IRA2 mutation reveals the phenotypic effects of the cryptic variants by disrupting the transcriptional silencing of one or more genes that contribute to the trait. Supporting this role for the IRA2 mutation, deletion of SFL1, a repressor that acts downstream of the Ras pathway, also reveals the phenotype, largely due to the same cryptic variants that were detected in the IRA2 mutant cross. Our results illustrate how higher-order genetic interactions among mutations and cryptic variants can result in phenotypic capacitance in specific genetic backgrounds, and suggests these interactions might reflect genetically complex changes in gene expression that are usually suppressed by negative regulation.

Indexed as

Polymorphism, GeneticTranscription, GeneticAllelesGene Expression Regulation, FungalMembrane GlycoproteinsMutationPhenotypeSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsSignal TransductionTranscription FactorsFLO11 protein, S cerevisiaeMembrane GlycoproteinsSaccharomyces cerevisiae ProteinsSFL1 protein, S cerevisiaeTranscription Factors

Identifiers

PMID26484664
PMCPMC4618523
OpenAlexW1780328778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.